CompletedNot Applicable

SMAS: a Prospective Study in a Single Institution

Italy39 participantsStarted 2008-10

Plain-language summary

Superior Mesenteric Artery Syndrome (SMAS) is a rare cause of duodenal obstruction, that should be suspected in cases of chronic, refractory upper digestive symptoms. Between 2008 and 2016, 39 consecutive patients with chronic gastrointestinal symptoms and a diagnosis of SMAS were prospectively included in the study, in order to describe their demographic, clinical and outcome features. All patients underwent duodenojejunostomy.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria (at least 2 of the following): * severe and frequent upper digestive symptoms (occurring at least once a week), associated to poor quality of life and refractory response to medical treatment; * a condition of underweight (BMI \<18.5 kg/m2) associated with difficulty eating; * severe complications of SMAS (e.g. gastric perforation, acute pancreatitis, aspiration pneumonia); * suggestive findings of SMAS at barium swallow; * diagnostic aortomesenteric angle and distance at CT/MR angiography. Exclusion Criteria: * inability to provide the informed consent; * malignancies; * bowel motility disorders; * severe psychiatric illness; * pregnancy; * impossibility to perform the required diagnostic workup.

What they're measuring

Symptom score

Timeframe: 47 months (IQR 34-72)

BMI

Timeframe: 47 months (IQR 34-72)

Need for medical treatment

Timeframe: 47 months (IQR 34-72)

Trial details

NCT IDNCT03416647

SponsorAzienda Ospedaliera di Padova

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-05

View on ClinicalTrials.gov More Superior Mesenteric Artery Syndrome trials